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Abstract
Higher-order structure influences critical functions in nearly all non-coding and coding RNAs.
Most single-nucleotide resolution RNA structure determination technologies cannot be used to
analyze RNA from scarce biological samples, like viral genomes. To make quantitative RNA
structure analysis applicable to a much wider array of RNA structure-function problems, we
developed and applied high-sensitivity selective 2'-hydroxyl acylation analyzed by primer
extension (SHAPE) to structural analysis of authentic genomic RNA of the xenotropic murine
leukemia virus-related virus (XMRV). For analysis of fluorescently labeled cDNAs generated in
high-sensitivity SHAPE experiments, we developed a two-color capillary electrophoresis approach
with zeptomole molecular detection limits and sub-femtomole sensitivity for complete SHAPE
experiments involving hundreds of individual RNA structure measurements. High-sensitivity
SHAPE data correlated closely (R = 0.89) with data obtained by conventional capillary
electrophoresis. Using high-sensitivity SHAPE, we determined the dimeric structure of the XMRV
packaging domain, examined dynamic interactions between a packaging domain RNA and viral
nucleocapsid protein inside virion particles, and identified the packaging signal for this virus.
Despite extensive sequence differences between XMRV and the intensively studied Moloney
murine leukemia virus, architectures of the regulatory domains are similar and reveal common
principles of gammaretrovirus RNA genome packaging.
Introduction
As is likely to be the case for essentially all coding and non-coding RNAs, higher-order
secondary and tertiary structures in viral genomes play numerous roles in replication.1–3
High-throughput selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE)
makes possible characterization of RNA structure at single-nucleotide resolution on the
kilobase scale and has proven to be a powerful approach for understanding structure-
function relationships in RNA.4–7 In a SHAPE experiment, conformationally flexible
(generally single-stranded) nucleotides react with 1-methyl-7-nitroisatoic anhydride (1M7),8
or another electrophilic SHAPE reagent,9,10 to create a covalent 2'-O-ribose adduct (Figure
1A). Sites of adduct formation are detected by primer extension using fluorescently labeled
primers. SHAPE primer extension products can be separated on commercially available
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which peak intensities correlate with local flexibility at each individual nucleotide in the
RNA (Figure 1B).13 These data are processed to yield a reactivity profile for every RNA
nucleotide (Figure 1C). SHAPE has been validated by analysis of RNAs with known
structures and was used to discover structure-function relationships in an entire HIV-1
genome,5,11 and in regulatory domains in the Moloney murine leukemia virus (MuLV).14,15
The sensitivity of SHAPE is limited by the generally poor detection limits of conventional
capillary electrophoresis instrumentation and requires ~3 pmol of RNA per experiment.4
This limitation is significant: Tens of liters of a highly optimized cell culture system were
required to obtain sufficient genome copies (~100 pmol) for analysis of an entire HIV-1
genome.5 High levels of background noise from light scattering, leakage of excitation light,
and electronic noise reduce the ability of conventional instruments to detect fluorescently-
labeled primer extension products.16 When optimized for low-abundance species, capillary
electrophoresis is, in principal, capable of detecting single molecules.17
To address the challenge of analyzing rare, biologically important RNAs, we have
developed an ultra-sensitive RNA structure analysis platform that employs a two-color
capillary electrophoresis instrument with zeptomole (10−21) instrument detection limits and
sub-femtomole sensitivity for complete SHAPE experiments comprised of hundreds of
individual structure measurements. Here we describe application of this technology to
analysis of a low-abundance gammaretrovirus, xenotropic murine leukemia virus related
virus (XMRV).18 Although XMRV is not likely to be a human pathogen,19,20 as originally
reported,18,21 this virus is an excellent example of a recently identified infectious agent
currently available in only low amounts. XMRV is evolutionarily related to the well-
characterized MuLV,22–25 suggesting that critical features of its structure and biology are
conserved. Here, we used high-sensitivity SHAPE to analyze scarce XMRV RNA gently
extracted from virions and inside viral particles. Despite extensive sequence differences
between XMRV and the MuLV, the regulatory domain architectures are similar, revealing
universal principles of retroviral RNA genome packaging.
Results
Design and construction of a highly sensitive capillary electrophoresis instrument
We sought to improve the detection limits of SHAPE experiments by designing and building
a robust, yet highly sensitive, capillary electrophoresis instrument. A single-mode fiber optic
cable with an integrated lens was used to focus the light from a dual color argon laser (488
and 514 nm) onto a capillary (Figure 2). The optical fiber enabled the laser to be placed at a
non-interfering distance and ensured robust alignment of the laser beam. A high-numerical
aperture microscope objective oriented at a right angle to the laser beam collected light from
the capillary and minimized collection of scattered excitation light. The microscope
objective was mated to an optical cube (Figure 2) with a dichroic filter to reflect green
wavelengths while transmitting yellow light. Collection lenses mounted into the cube
focused the light onto a multimode optical fiber that acted as a spatial filter to remove
scattered light and transfer fluoresced light to the detector. Once the optical path was
aligned, the cube rigidly maintained the positions of the various components so that
realignment was required infrequently. Filters specific for each fluorophore were placed
between the optical cube and the detector photomultiplier tubes. The multimode fibers
permitted the detectors to be placed at a distance from the optical cube facilitating alignment
of the optical system and minimizing interference from high voltage capillary
electrophoresis. The melding of these individual innovations yielded a robust and reliable
optical system for the study of RNA structure.
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Detection limits for free fluorophores and for a complex SHAPE library
The limits of detection for the capillary electrophoresis instrument for the free 5-FAM and
6-JOE fluorophores used in our SHAPE experiments were determined by analysis of serially
diluted free dyes. Dilutions were analyzed until a signal-to-noise ratio of 3:1 could no longer
be maintained (Supplementary Figure 1). For 5-FAM, the detection limit was 20 zeptomoles
(2 × 10−20 mol), or 10,000 molecules. For 6-JOE, the limit was ten-fold higher at 200 zmol
(2 × 10−19 mol).
We then validated the ability of the system to separate, visualize and quantify hundreds of
fluorescent peaks simultaneously as required in a SHAPE experiment. We performed
dideoxy sequencing reactions26 using an in vitro transcript corresponding to an RNA
regulatory signal in the MuLV RNA.25 One fmol of input RNA, or 1,000 times less than that
required for a conventional instrument, was used. After primer extension, 59 ± 5% of the
input RNA was converted to fluorescently labeled cDNA, (see Methods). Throughout this
work, amounts are reported in terms of the input RNA. Triplicate measurements were highly
reproducible with standard deviations less than 5% per nucleotide position (Supplementary
Figure 2A). We also compared data from a SHAPE reaction on the MuLV RNA obtained
with a conventional instrument using 1 pmol RNA versus with the high-sensitivity
instrument using 1 fmol of the same sample (Supplementary Figure 2B). The two
electropherograms are highly similar (R = 0.90) (Supplementary Figure 2C).
We next used the in vitro MuLV transcript to determine the SHAPE limit of detection. We
probed the structure of this RNA by SHAPE using 1M7,8 and the resulting fluorescently
labeled cDNA fragments were resolved by both conventional and high-sensitivity capillary
electrophoresis. For a cDNA pool derived from 10 fmol of input RNA, we resolved peaks
corresponding to all 170 nucleotides in the MuLV RNA using the high-sensitivity
instrument (Figure 3A, left). Experiments corresponding to the (+) reagent and no-reagent
control reactions were resolved in separate capillary electrophoresis runs, each also
containing the same sequencing marker. These data were combined and processed as a
single experiment (see Methods) to obtain a SHAPE reactivity profile (Figure 3B, left) and
compared to data from a conventional instrument using 100 times more input RNA. The
integrated intensities from the high sensitivity instrument correlated closely with data from a
conventional instrument; the R-value is ≥0.89 (Figure 3C, left). Next, we sequentially
diluted the SHAPE-produced cDNA library until a 3:1 signal-to-noise ratio was reached.
This occurred at a dilution corresponding to 100 amol input RNA (Figure 3A and B, right
panels). At this level of input RNA, the usable data eventually decays to a level below the
instrument detection level due to drop-off12,23 associated with the reverse transcription step
(Figure 3A, right panel).
We estimated the amount of cDNA injected into the instrument at the 100 amol RNA
dilution using electrokinetic injection calculations.27 The quantity injected, Q (in moles),
onto the capillary electrophoresis instrument is proportional to the sum of electrophoretic
(μep) and electroosmotic (μeo) velocities of the DNA in the polymer-filled capillary
(1)
scaled by the capillary area (πr2), the electric field strength (E), the input RNA concentration
(C) and the injection time (ti). The electro-osmotic mobility is approximately zero in this
system (data not shown) and cDNA electrophoretic mobility is approximately equal to the
length of the capillary divided by the separation time, ts (the time between cDNA injection
and fluorescent primer peak detection),28 thus:
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For a solution containing 100 amol input RNA, approximately 1 amol of cDNA was
physically injected into the instrument [L = 36 cm, E = 217 V/cm, ts = 875 s (measured for
the primer DNA, and thus a lower limit), C = 10 pM (100 amol / 10 μL) and ti = 30 s].
Given that 20 zmol of cDNA are required to visualize a single peak (nucleotide) in the
electropherogram (Supplementary Figure 1), 3.4 amol (170 nucleotides × 20 zmol)
represents the minimal sample quantity sufficient to report a SHAPE experiment for the
MuLV packaging domain.
Thus, at 1 amol of cDNA injected onto the instrument, roughly one-third too few molecules
are present to fully represent the entire SHAPE profile. Consistent with this calculation for
the 100 amol SHAPE limit of detection, ~60 nucleotides of SHAPE data in the
electropherogram integrate to zero or near-zero values, reflecting signal decay that results
from imperfect processivity of the reverse transcriptase enzyme used to generate the cDNA
pool and a two-fold reduction in injection efficiency for the longest cDNAs (Figure 3A and
B, right panels, gray bar). These positions also exhibit an accumulation of zero magnitude
points along the x-axis in a correlation plot (Figure 3C, right). Strikingly, at this SHAPE
limit of detection, the data are nevertheless still highly correlated with data obtained using
conventional instrumentation at 1 pmol RNA (R ≥ 0.85). Ultra-sensitive SHAPE thus yields
accurate RNA structural information up to, and even beyond, the limit of fluorophore
detection.
Accurate, nucleotide-resolution secondary structure prediction by ultra-sensitive SHAPE
SHAPE reactivities are inversely correlated with the probability that a nucleotide is base
paired, and it is therefore possible to use SHAPE information to predict RNA secondary
structures accurately.29,30 We used the nucleotide-resolution SHAPE data obtained at 10
fmol and 100 amol, equal to 100 and 10,000 fold lower concentrations than measurable
using conventional instrumentation, to direct RNA secondary structure predictions for the
MuLV packaging domain. This 170-nucleotide RNA corresponds to a regulatory domain at
the 5' end of the MuLV RNA genome31 that links two viral genome strands into a dimeric
structure and comprises the “packaging signal” responsible for directing the full genome
into nascent viral particles.32 Point mutations in this domain can reduce packaging to non-
specific levels.25 The MuLV regulatory domain has been extensively characterized both
structurally and biologically and forms a well-defined monomeric structure in the absence of
magnesium ion.
The lowest free energy structures for the MuLV packaging domain were calculated using
either thermodynamic nearest-neighbor constraints alone or thermodynamic nearest-
neighbor constraints and SHAPE reactivity data included as pseudo-free energy
constraints.29 Structure predictions were evaluated by their sensitivity (the percent correctly
predicted base pairs) and positive predictive value (PPV, the percentage of predicted pairs
that are present in the accepted structure). In the absence of SHAPE data, the secondary
structure of the MuLV RNA was predicted with sensitivity and PPV values of 36% and
35%, respectively. There were thus significant errors relative to the accepted structure,14 as
shown in Figure 4A. We then predicted the structure using SHAPE data as pseudo-free
energy change constraints.29,33 The resulting base pair sensitivities were 100 and 90%,
respectively, and no incorrect base pairs were proposed (PPV = 100%) (Figure 4B and 4C).
Consistent with the strong correlation observed between the ultra-sensitive SHAPE data and
data obtained by using pmol RNA amounts, ultra-sensitive SHAPE yielded accurate
secondary structure predictions with as few as 100 amol, or 10,000 molecules, of RNA.
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Ultra-sensitive SHAPE analysis of authentic XMRV
We then analyzed a 184-nucleotide region near the 5' end of the XMRV RNA genome that
is functionally homologous to the MuLV dimerization and packaging regulatory domain.
SHAPE reactivity measurements were obtained using 50 fmol aliquots of XMRV genomic
RNA that had been gently extracted from virions purified from cell culture,34 using the
22RV1 virus-producing cell line.35 Integrated SHAPE reactivities (Figure 5A), taken
together with comparison to prior structural analysis of MuLV, were used to develop a
model for the structure of this regulatory domain. SHAPE probing data of RNA isolated
from virions indicated clearly that the XMRV genome was present as a dimer in mature viral
particles. The overall architecture is similar to that of MuLV and includes four key dimer
interaction elements. Two palindromic sequences, termed PAL1 and PAL2, form
intermolecular duplexes in the dimeric structure, as evidenced by their uniformly low
SHAPE reactivities (Figure 5B). In contrast, when these structures are forced to fold in a
monomeric conformation, the lowest free energy models contain several structures with
reactivities that are incompatible with the SHAPE data (Supp. Figure 5). The apical loops in
SL1 and SL2 form intermolecular loop-loop kissing interactions, as these nucleotides are
unreactive towards SHAPE and by analogy with previous work on MuLV (Figure 5B).23
We next analyzed the structure of the XMRV genome inside viral particles, again using fmol
quantities of RNA. Intact viral particles were treated with the 1M7 SHAPE reagent, the
modified RNA was extracted from the virions and primer extension products were
quantified by ultra-sensitive SHAPE. Because SHAPE data are highly reproducible, the net
effect of different environments – including a complex in virio environment – can be readily
characterized by subtracting one SHAPE profile from another to yield a difference plot
(Figure 5C). The difference analysis revealed three major regions that were less reactive, or
protected, in virions relative to the gently extracted genomic RNA and one segment that was
more reactive in virions (in blue, Figure 5C). These experiments, performed on fmol
amounts of a structurally uncharacterized authentic retroviral RNA genome, provided strong
clues as to the mechanism of genome packaging in XMRV.
Discussion
Most biologically important RNAs are present at very low levels. As a result, studies on
these RNAs have been limited to indirect functional studies or direct experimental studies
using in vitro transcribed RNA as models. Recent work blending SHAPE with next-
generation sequencing has lowered detection limits by a factor of ten, to the tenth-picomole
(10−13) level.7 Analysis of scarce RNAs might be further optimized by RT-PCR approaches
but care must be taken so that amplification steps do not reduce the quantitative accuracy of
the resulting structural information.36 In this study, we increased the molecular sensitivity of
the SHAPE nucleotide-resolution RNA structure probing technology to sub-femtomole
(10−16) levels, or four orders of magnitude, by implementing multiple innovations to
achieve highly sensitive capillary electrophoresis detection of the fluorescently-labeled
cDNA primer extension products.
Using ultra-sensitive SHAPE, we examined the structure of the dimerization and packaging
regulatory domain of XMRV genomic RNA gently extracted from virions and also within
authentic virions. The ultra-sensitive SHAPE data obtained on authentic viral RNA strongly
support a model in which XMRV is present as a dimer in mature virions (compare Figures
5B and Supp. Figure 5). Genomic dimerization is mediated by four key intermolecular
interactions at PAL1, PAL2, SL1 and SL2 sequences (Figure 5B). Remarkably, even though
there are extensive sequence differences and nucleotide insertions in XMRV relative to
MuLV (Supplementary Figure 3), the structures of their respective packaging domains are
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conserved. It is likely that a similar dimeric architecture is evolutionarily conserved among
many gammaretroviruses.
The dimerization and packaging domain in the MuLV virus has been intensively studied and
packaging of the RNA genome involves, in part, a binding interaction between the
nucleocapsid (NC) domain of Gag and a specific sequence of nucleotides in the RNA.37 The
MuLV NC protein binds tandem repeats of the sequence UCUG. The strongest interactions
occur at the first U and final G of the motif and this single-stranded element must be flanked
by helical regions for highest-affinity binding.25 There are two such elements in the MuLV
RNA genome and these elements constitute the RNA packaging signal for this virus.25
In contrast, inspection of the SHAPE reactivity differences in the XMRV packaging domain
for the ex virio and in virio RNA revealed three strong sets of protections. By analogy with
previous work on MuLV25, virion-specific protection from SHAPE reactivity is likely due
to protein binding. Virion-specific increases in reactivity are most directly attributed to RNA
conformational changes. Two of these three motifs are unique to XMRV as compared to
MuLV. The first unique motif (Figure 5C, motif a) has the sequence UCUGUCUUUG and
is positioned between the structured elements PAL1 and SL0 (see boxed nucleotides 238–
247, Figure 5B). The second motif, UCUGAAUCUG, has no analog in MuLV (Figure 5C,
motif b) and is partially occluded by the SL0 helix in the model for the deproteinized RNA
(Figure 5B, nucleotides 289–298). Difference plot analysis suggested that the base of helix
SL0 is disrupted upon NC binding and has a different conformation inside the virion.
(Figure 5C, region d). This model is supported by differences within SL0 in the in virio state
compared to the ex virio state (Figure 6, doubleheaded arrow). It is also consistent with the
known nucleic acid chaperone properties of NC.38 The third motif in (Figure 5C, motif c),
UCUGUAUCUG, is identical in both position and sequence to that in MuLV (Figure 5B,
nucleotides 318–327). These three flexible regions in XMRV, consisting of some form of
the sequence UCUGRRURUG (Figure 6, see regions a, b and c), are flanked by well-
defined RNA helices and interact most strongly with NC at the first U and last G nucleotides
within these motifs (capitalized in Figure 6, lower panel).
In conclusion, high sensitivity SHAPE has made possible structural analysis of a rare,
recently discovered, authentic genomic viral RNA. SHAPE characterization of the XMRV
RNA within virion particles revealed functional determinants of a structure critical for
packaging. XMRV appears to use a genome packaging strategy that is similar to that
employed by MuLV, but has distinct and more complex features (Figure 6). We anticipate
that by making analysis of femtomole quantities of RNA possible, high sensitivity SHAPE
technologies will accelerate functional and structural characterization of many low
abundance RNAs, including viral genomes, rare biological mutants, and, with further
refinement, complex mixtures like messenger RNAs and clinical samples.
Experimental Procedures
Instrument design and construction
The high-sensitivity capillary electrophoresis laser-induced fluorescence instrument is of
custom design and construction (see Supplementary Figure 4).39 The detector utilizes a
right-angle excitation design (Figure 2). A single-mode fiber-optic cable with an integrated
lens (3.5-cm focal length, Oz optics) was used to focus the beam from a multiline argon
laser (488 and 514 nm, JDS Uniphase) into the lumen of a capillary. Light from the capillary
was collected using a microscope objective (40×, 0.75 na, Plan Fluor, Nikon). The laser and
capillary were positioned with respect to each other using an XYZ stage (Newport). A
dichroic filter (FF550-Di01-25×36, Semrock) was used to divide the collected light into the
5-FAM and 6-Joe wavelengths. Collection lenses (two collimators for single-mode fiber/
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HPUCO-23-400/700-M-50AC-30OD, Oz Optics) were used to direct the light into
multimode optical cables (200/230 μm multimode IRVIS fiber/ QMMJ-33-
IRVIS-200/230-3-1, Oz Optics). The entry-way into the fiber optic cable also acted as a pin
hole to spatially filter the light and remove residual scattered excitation light. Bandpass
filters (525 and 565 nm; FF01-525/20-25, FF01-565/24-25, Semrock) appropriate for each
fluorophore were used to further remove excitation light prior to entry into the detector. The
light was detected, amplified and converted to current using a photomultiplier tube (PMT,
H7732, Hamamatsu) mounted in a custom housing with shutters and filter slots. Current
from the PMT was amplified and converted to voltage using a preamplifier (Advanced
Research Instruments). The signal was then digitized using an analog to digital board
(National Instruments) and the instrument was controlled via a custom Labview program
designed in conjunction with the UNC Chemistry department electronics shop (available
upon request). Prefabricated 310 Genetic Analyzer capillaries 47 cm in length with a 50-μm
inner diameter (Applied Biosystems) were constructed to have an optical window 36 cm
from the inlet. Two nonconductive columns were mounted on either side of the optical unit
to accommodate the capillary inlet, outlet, and custom-built capillary washing system. The
capillary electrophoresis system was powered by a high voltage power supply (Spellman). A
full set of mechanical drawings is available upon request.
Instrument limit of detection
Experiments to determine instrumental detection limits were performed using free 5-FAM
and 6-JOE fluorophores. Samples, diluted from a 10 μM stock, were hydrodynamically
injected into the system by elevating the capillary at the sample inlet by 10 cm for 12 s to
permit sample introduction via siphoning. The volume of sample injected at 0.17 nL/sec27
into the 50-μm capillary using gravity injection was thus approximately 2 nL. Experiments
were carried out in triplicate (Supplementary Figure 1). The capillary was filled with 100
mM borate (pH 8) and samples were separated at 6 kV for 10 min. Samples were diluted
until an integrated fluorescence signal-to-noise ratio of 3:1 was no longer maintained. The
signal-to-noise ratio was calculated by dividing the integrated fluorescence by standard
deviation of background signal from the first 100 s after injection.
Retroviral RNA transcripts
The in vitro MuLV RNA construct is 331 nucleotides and spans the dimerization and
packaging regulatory domain (~170 nts) including 5' and 3' flanking sequences of 46 and
115 nucleotides, respectively.14,17,24 The transcript was generated and purified as
described.25
Isolation of XMRV
XMRV was obtained from the constitutively producing XMRV cell line, 22Rv1 (ATCC),35
cultured in RPMI media with 10% (vol/vol) fetal bovine serum. Culture fluids were
collected and filtered, first through 1-μm then 0.45-μm filters, before virus was isolated by
continuous-flow ultracentrifugation.34 Virus was subtilisin-treated as described40 and
collected by centrifugation through a 3.6-mL 20% (wt/vol) sucrose (in PBS without Ca2+ or
Mg2+) cushion at 390,000 × g for 2 h at 4 °C. The supernatant was removed, the viral pellet
was overlaid with ice-cold PBS (without Ca2+ or Mg2+) and the sample was centrifuged for
an additional 1 hr at 4 °C. The supernatant was aspirated and the pellets were resuspended in
600 μL HNS buffer [50 mM HEPES (pH 8.0), 200 mM NaCl, 0.1 mM EDTA, 10% (v/v)]
for further manipulations, described below.
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XMRV RNA, gently extracted from XMRV virions as described previously,15 was
incubated in 1× folding buffer [50 mM HEPES (pH 7.5), 200 mM potassium acetate (pH
7.5), and 5 mM MgCl2] at 37 °C for 20 min prior to modification. The resuspended virus in
HNS buffer (300 μL) was pipetted into 33.3 μL 50 mM 1M7 (1-methyl-7-nitroisatoic
anhydride) in DMSO (plus reagent) or neat DMSO (minus reagent), mixed by pipetting and
incubated at 37 °C for 15 min to modify RNA. Virions were collected by ultracentrifugation
as described.40 Virion resuspensions were preincubated at 37 °C for 5 min and 300 μL of
virus solution was pipetted into 33 μL solutions of either 1M7 (50 mM) or DMSO at 37 °C.
Solutions were mixed by pipetting and incubated for 15 min at 37 °C. Samples turn from
faint yellow to dark orange upon reaction with 1M7. Samples were resuspended in 100 μL
of 1× lysis buffer [50 mM Hepes (pH 7.5), 200 mM NaCl, 3 mM MgCl2] and lysed with 1%
(wt/vol) SDS and 20 mg/mL proteinase K at 22 °C for 30 min. The lysate was extracted four
times with phenol/chloroform/isoamyl alcohol (25:24:1), followed by four extractions with
pure chloroform. Samples were then precipitated with ethanol and stored in 70% ethanol at
−20 °C until primer extension.
In vitro generated MuLV RNA monomer transcripts (2 pmol) were renatured by heating at
95 °C for 3 min in 12 μL water, cooled on ice for 3 min and equilibrated at 37 °C for 3 min
in a folding buffer without magnesium [50 mM HEPES (pH 7.5), 200 mM potassium acetate
(pH 7.5)]. SHAPE modification was performed by treating 9 μL MuLV RNA with 1 μL
1M7 (50 mM in DMSO), followed by incubation at 37 °C for 2 min. RNA was recovered
using a precipitation approach optimized for the quantitative recovery of low abundance
RNAs [2.5 vol ethanol, 1 vol isopropanol, 1 μL glycogen (20 mg/mL); incubation at –20 °C
for 60 min; and centrifugation at 20,000× g]. Pellets were resuspended in 6 μL 1/2× TE [5
mM Tris, 0.5 mM EDTA (pH 8.0)] buffer.
Primer extension
The general protocol was described in detail previously.4,14 DNA primers incorporated
locked nucleic acid nucleotides (LNA, underlined below) for use on low-copy RNA to
increase binding affinity and stringency.41–43 The efficiency of primer extension using
LNA-containing primers was calculated to be 59 ± 5% based on the fraction full-length
extension product relative to the sum of this value and the unextended primer peak after
correcting for the two-fold excess of primer over RNA target, using electropherograms from
a no-reagent control reactions. MuLV primers (5'-GGUGC ACCAA AGAGU CCAAA
AGC-3', 5'-end labeled with 5-FAM or 6-JOE) annealed 3' of the MuLV dimerization
domain (nucleotides 422 to 445) XMRV primers (5'-GAAGT CTCTG TCTCT CGTCC
CCC-3') annealed to nucleotides 443 to 468 in the genome sequence. Primers (0.5 μL; 2
fmol) were annealed to XMRV RNA (6 μL; 1 fmol in 1/2× TE buffer) by heating at 65 °C
and 45 °C for 5 min and then snap-cooled on ice. Reverse transcription buffer [3 μl; 200
mM Tris (pH 8.0), 250 mM KCl, 10 mM MgCl2, 2 mM each dNTP, 20 mM DTT] was
added at 0 °C, and primer extension was performed with Superscript III (Invitrogen) reverse
transcriptase (0.5 μl; 100 U) at 45 °C for 1 min, followed by incubation at 52 °C and 65 °C,
for 10 min each. MuLV transcript RNA was subjected to primer extension exactly as
described above except that primer and RNA concentrations were 2 and 1 pmol,
respectively. Reactions were quenched by cooling to 4 °C and addition of 3 M sodium
acetate (pH 5.2). A sequencing marker was generated by adding 0.5 μL dideoxy-GTP (10
mM) to the primer extension reaction mixture using unmodified RNA. The 1M7 and DMSO
reaction mixes were each combined with equal amounts of dideoxy-GTP-terminated
sequencing ladders, precipitated with ethanol, and resuspended in deionized formamide (20
μl).
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For conventional capillary electrophoresis, cDNA fragments were resolved on an Applied
Biosystems 3130 instrument. This instrument is fully automated for use with high
abundance cDNA samples of ~1 pmol or greater. The samples were loaded in microtiter
plates and injected onto the instrument using standard instrument protocols. MuLV and
XMRV cDNA fragments, ranging in concentration from 100 amol to 50 fmol of input RNA,
were resolved by custom high-sensitivity capillary electrophoresis. For ultra-sensitive
SHAPE, samples of 1 to 10 μL were electrokinetically injected (10.2 kV for 30 s) onto a 47
cm (50-μm inner diameter) uncoated capillary containing Pop7 (Applied Biosystems) as the
internal polymer. The detection window was placed at 36 cm. Voltage was applied using
positive polarity (10.2 kV for 60 min) and immersing the capillary ends in a 1× running
buffer (Applied Biosystems). The PMT voltages were 0.9 kV and the laser power was 2
mW. Excitation was achieved using an argon laser at 488 and 514 nm wavelengths focused
within the capillary at the detection window. 5-FAM was used to detect cDNAs
corresponding to SHAPE structure probing and the lower sensitivity dye, 6-JOE, was used
for sequencing. A single high-sensitivity SHAPE experiment was thus resolved in two
separate capillary electrophoresis runs, one each for the plus- and no-reagent reactions.
Sensitivity for sequencing is not a critical issue because sequencing can be performed with
an in vitro transcript or with DNA rather than with a scarce biological sample.
Data processing and structure prediction
Raw sequence traces were corrected for dye variation and signal decay; peak intensities
were integrated using ShapeFinder.12 Traces were analyzed by combining data from two
separate capillary runs. Each capillary electrophoresis separation contained (i) a reaction
performed in the presence or absence of 1M7 (detected using a FAM-labeled primer) and
(ii) a sequencing reaction (labeled with JOE) performed using dideoxy GTP. Data from the
two runs were aligned using the identical sequencing lanes and then analyzed as described.12
SHAPE reactivities were normalized by dividing by the average intensity of the 10% most
reactive nucleotides, after excluding outliers found by box plot analysis.29 SHAPE reactivity
information was used to impose a pseudo-free energy change constraint in conjunction with
nearest neighbor thermodynamic parameters in the prediction program RNAstructure.29,30,33
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SHAPE Overview
(A) Mechanism of RNA SHAPE chemistry. Hydroxyl-selective electrophiles modify the 2'-
OH group of flexible RNA nucleotides (red) to create a 2'-O-adduct. (B) Subsequent
detection of 2'-O-adducts by primer extension and separation by capillary electrophoresis
yields an electropherogram of fluorescent peaks. Peak volumes correspond to SHAPE
reactivity. (C) Integrated peak intensities after background subtraction.
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Figure 2. Robust, high sensitivity, capillary electrophoresis instrument design
Photograph and schematic of the high-sensitivity instrument. The optical cube design
maximizes light detection and minimizes background noise within each of the three main
capillary electrophoresis instrument components: excitation, emission and data acquisition.
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Figure 3. SHAPE limit of detection using MuLV
(A) Processed electropherograms and (B) quantitative SHAPE reactivities for MuLV RNA
treated with 5 mM 1M7 are shown for cDNA pools corresponding to 10 fmol and 100 amol
of input RNA. Regions labeled in gray in the 100 amol experiment represent data that fall
below the statistical detection limit at the end of the electropherogram due to signal decay
during primer extension.11,12 (C) Correlation between SHAPE reactivities, measured at 10
fmol and 100 amol of input RNA, with an identical experiment resolved by conventional
capillary electrophoresis instrumentation at 1 pmol input RNA. The full datasets span a
range from 0 to ~2 but only data to 1.0 are shown to emphasize the strong best-fit correlation
for the most information-rich measurements. R-values for the full data range are higher, at
0.95 and 0.89, respectively.
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Figure 4. SHAPE-directed folding of the MuLV genomic RNA monomer
(A) Secondary structure of the MuLV monomer in the packaging domain as predicted using
thermodynamic constraints alone. Missed base pairs and incorrectly predicted base pairs
relative to the accepted structure14 are denoted by green lines and red x's, respectively. (B
and C) MuLV monomer structures predicted using SHAPE constraints to direct RNA
secondary structure predictions. Data were obtained at 10 fmol and 100 amol input RNA.
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Figure 5. Structural analysis of authentic XMRV genomic RNA
(A) Integrated SHAPE data obtained by treatment of XMRV genomic RNA with 5 mM
1M7. (B) Secondary structure model for the XMRV RNA genome in the dimer state.
Experimental SHAPE data from panel A are superimposed as nucleotide colors. Key
interaction elements that stabilize the dimer structure are labeled. NC binding motifs
identified in this work are boxed. (C) SHAPE reactivity differences between the RNA gently
extracted from virions versus the genomic RNA modified inside virion particles. Positive
amplitudes indicate nucleotides that are protected from SHAPE reaction in virio relative to
the protein-free ex virio RNA.
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Figure 6. Model for XMRV retroviral genome packaging
Secondary structure model for the NC domain of Gag bound to the XMRV packaging signal
RNA. Regions with the largest changes in SHAPE reactivity for the RNA analyzed inside
virions, relative to the ex virio RNA, are identified (a–d, bottom panel) with the same labels
used in Figure 5C. Within each NC binding site (ovals), nucleotides showing the strongest
protections inside virions are emphasized with large lettering. Conserved helical elements
that stabilize the dimer state and do not differ in conformation when in virio and ex virio
data are compared are shown schematically as cylinders; these helices flank single-stranded
regions bound by NC and are components of the protein binding site.25
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